Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 41761580

DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma.

Kristen L Drucker·Arijit Panda·Paul A Decker·Matt L Kosel·Thomas M Kollmeyer·Terry C Burns·Muhammad Asad Maqbool·Shameel Shafqat·Milovan Suvakov·Gelareh Zadeh·Caterina Giannini·Rachael Vaubel·Aditya Raghunathan·Ian F Parney·Sani H Kizilbash·Cristiane M Ida·Alexej Abyzov·Daniel H Lachance·Jeanette E Eckel-Passow·Robert B Jenkins
View original source ↗Export metadata ↓

Abstract

BACKGROUND: Current literature suggestsisocitrate dehydrogenase (IDH)-mutant astrocytoma contains several molecular subgroups. In this study, we are interested in determining the connection between different molecular subgroups with grade and/or survival. METHODS: A cohort of 470 Mayo Clinic adult patients (&#x2265;18 years, 56.2% male) with primary IDH-mutant astrocytoma diagnosed by World Health Organization (WHO) 2021 criteria were examined. Results were validated in an independent cohort of 614 Mayo Clinic Neuropathology consult patients and 235 The Cancer Genome Atlas (TCGA) patients. RESULTS: The Mayo Clinic Practice cohort confirmed the association of CDKN2A/B deletion with overall survival (OS, homozygous vs hemizygous vs intact, 2.7 vs 9.6 vs 17.2 years, P&#x2009;<&#x2009;.001). Phosphatase and tensin homolog (PTEN) deletion was also associated with poor OS (7.3 vs 17.4 years, P&#x2009;<&#x2009;.001). Increased number of copy number alterations was associated with OS (continuous variable, HR&#x2009;=&#x2009;1.027, P&#x2009;<&#x2009;.001). Carrying one or more copies of the germline risk allele at rs55705857 was associated with earlier age of onset (median age 33 vs 35 years, P&#x2009;=&#x2009;.01), and a shorter OS after adjusting for age, grade, sex and treatment (HR&#x2009;=&#x2009;1.81, P&#x2009;=&#x2009;.007). The Mayo Clinic Neuropathology Consult cohort and TCGA were utilized to validate age of onset and survival, respectively. Unsupervised clustering of the copy number alterations identified several clinically significant groups that may define pathways to disease progression. Losses of chromosomes 11p, 13q, 1p, and 10q were all associated with reduced overall survival in the Mayo Clinic cohort. CONCLUSIONS: Patients with hemizygous loss of CDKN2A/B, loss of PTEN, increased number of copy number alterations, specific chromosomal arm losses or rs55705857 germline risk allele have reduced overall survival.

Explore related subjects

HumansAstrocytomaIsocitrate DehydrogenaseDNA Copy Number VariationsPrognosisBrain NeoplasmsFemaleMutationBiomarkers, TumorMaleMiddle AgedPTEN PhosphohydrolaseAdultSurvival RateFollow-Up StudiesCDKN2A/BPTEN8q24 rs55705857IDH-mutant &#xad;astrocytomacopy number complexityJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kristen L Drucker, Arijit Panda, Paul A Decker, Matt L Kosel, Thomas M Kollmeyer, Terry C Burns, Muhammad Asad Maqbool, Shameel Shafqat, Milovan Suvakov, Gelareh Zadeh, Caterina Giannini, Rachael Vaubel, Aditya Raghunathan, Ian F Parney, Sani H Kizilbash, Cristiane M Ida, Alexej Abyzov, Daniel H Lachance, Jeanette E Eckel-Passow, Robert B Jenkins. 2026-06-01. DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma.. https://doi.org/10.1093/neuonc%2Fnoag019

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗